To study genomic events contributing to breast cancer, numerous genetically engineered mouse models have been generated, including MMTV-Neu1 which recapitulates HER2+ve breast cancer, and MMTV-Polyoma virus Middle T antigen (PyMT)2. This evidence concerns the gene ERBB2 and breast carcinoma.